Meeting Banner
Abstract #3084

Assessment of Passive Tumor Targeting of a Novel PFCE-Loaded Nanoemulsion via 19F-MRI

Lawrence M Lechuga1, Alexa R Barres2, Montira Tangsangasaksri3, Paul Begovatz1, Sandro Mecozzi3,4, and Sean B Fain1,5,6
1Medical Physics, University of Wisconsin, Madison, Madison, WI, United States, 2Morgridge Institute for Research, Madison, WI, United States, 3Pharmacy, University of Wisconsin, Madison, Madison, WI, United States, 4Chemistry, University of Wisconsin, Madison, Madison, WI, United States, 5Biomedical Engineering, University of Wisconsin, Madison, Madison, WI, United States, 6Radiology, University of Wisconsin, Madison, Madison, WI, United States

Fluorine-19 MRI is a method that can utilize biocompatible perfluorocarbons to detect cancer. Implementation of a novel nanoemulsion has allowed for improved particle stability and PFC loading. Tumor-bearing mice were injected with perfluoro-[15-crown-5]-ether (PFCE) loaded nanoemulsion (NE) to explore the passive tumor targeting across 14 days. 19F MRI and subsequent ROI-image analysis suggested that there was a preferential retention of NE particles due to the enhanced permeability and retention (EPR) effect. This work demonstrates repeatable 19F imaging of a novel nanoemulsion that passively targets a fast growing tumor with improved stability and PFCE loading.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords